Amurtab
@Amurtab
Followers
82
Following
754
Media
13
Statuses
146
Pharmacist, Postdoctoral Fellow @UAlberta_Pharm š®š·šØš¦
Joined December 2015
RT @JussherLab: This will likely be my last thread here as Iām moving over to Bluesky (, but wanted to share excitiā¦.
0
1
0
Super excited for @SaedChristina for landing the @CIHR_IRSC postdoctoral fellowship and finishing her PhD at the same time! Way to go, so proud of you!.
1
1
5
RT @Filip_Knop: New systematic review and meta-analysis: RCT data from 16,839 placebo- and 16,550 semaglutide-treated patients and 13,330 rā¦.
0
25
0
RT @DanielJDrucker: Now free to read ā¦@NatRevCardiolā© #heartdisease #diabetes #T2D #obesity #heartfailure ā¦@JussherLabā© .
0
36
0
RT @JasonRBDyck: Iām pleased to share our recent review published in @NatureCVR about Ketones and the Cardiovascular System. A pleasure worā¦.
nature.com
Nature Cardiovascular Research - Lopaschuk and Dyck review the bioenergetic and signaling effects of ketones on the cardiovascular system and discuss the potential application of ketones for...
0
31
0
Thank you @CIHR_ICRH for giving me this opportunity to pursue my passion and make a difference. This would have been impossible without the support of my brilliant mentor. I am forever grateful to @JussherLab for reshaping me into the person and researcher I am today.
some very exciting news to share that @Amurtab received a fellowship from @CIHR_IRSC and we look forward to sharing his current work on developing new pharmaceutical agents that decrease #ketone #oxidation to promote #glucose_lowering in the future!
1
0
15
RT @JussherLab: Itās been a while since I used Twitter for this, but our lab is looking to recruit a new #postdoc, if anyone is interestedā¦.
0
49
0
RT @UAlberta_Pharm: RESEARCH PROJECT: Development of succinyl-CoA:3-ketoacid CoA transferase (SCOT) inhibitors for the treatment of Type 2ā¦.
0
3
0
RT @UAlberta_Pharm: RESEARCH PROJECT: Myocardial Ketone Body Oxidation as a Therapeutic Target for Diabetic Cardiomyopathy."Therapies specā¦.
0
3
0
RT @UAlberta_Pharm: "We believe that finding a better target for diabetic heart disease with less potential for adverse effects would improā¦.
0
3
0
RT @JussherLab: Just got back from #Seoul and missed this coming online, but really excited to share our labās latest research looking at tā¦.
diabetesjournals.org
Despite significant progress in understanding the pathogenesis of type 2 diabetes (T2D), the condition remains difficult to manage. Hence, new therapeutic
0
3
0
RT @NatMetabolism: Online now! GTTs and ITTs: aim for shorter fasting times
0
6
0
RT @kerrymcphail1: I have to admit when first learning of the Michaelis-Menten equation decades ago (in Zimbabwe), my mental image was of tā¦.
0
8
0
RT @AlbertaDiabetes: Congratulations to our @AlbertaDiabetes members and their teams who were awarded funding for the 2021 Spring @CIHR_IRSā¦.
0
6
0
RT @RyanDhindsa: Really excited to share our manuscript "Rare variant contribution to human disease in 281,104 UK.2 Biobank exomes" now pubā¦.
nature.com
Nature - The authors analyse rare protein-coding genetic variants for association with 18,780 traits in the UK Biobank cohort.
0
47
0
RT @CellCellPress: In the latest issue! An atlas of protein-protein interactions across mouse tissues
0
43
0
RT @JeanMacklaim: Emma Allen-Vercoe: āYou are not human. microbes outnumber human cells 1.3:1. But for a brief moment after a bowel movemenā¦.
0
8
0
RT @PTurnbaugh: Our new paper @Nature is an epic tale of obesity, calories, gut microbes, and C. difficile. Trainees interested in contribuā¦.
0
106
0